FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early Psychosis

Recruiting N/A Interventional Study
Delusional Disorder Brief Psychotic Disorder Schizophreniform Disorder Schizophrenia / Schizoaffective Disorder Other Psychotic Disorder Not Due to A Substance or Known Physiological Condition
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
16 – 35
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
252 (estimated)
Sponsor
Stephanie Mehl · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
FEEL-GOOD is a prospective multi-site single-blinded randomized controlled trial in young inpatients with acute early psychosis. Participants are randomized 1:1 to FEEL-GOOD plus treatment as usual (TAU) or TAU alone. The intervention consists of one individual preparatory session and eight modularized group sessions delivered over four weeks involving four to eight participants at each session an…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age 16 to 35 years * Clinical diagnosis of early psychosis, defined as first psychotic episode within the last 5 years as assessed with the Structural Clinical Interview for DSM-5 Research Version (SCID-5-RV) * DSM-5 schizophrenia spectrum or other psychotic disorder confirmed…
Contacts

Mara Bach

+49 (0) 130 226095

Mara.bach@charite.de

CONTACT

Isabella Zimmermann

+49 (0) 30 450 676 368

isabella.zimmermann@vivantes.de

CONTACT